ARCON: experience in 215 patients with advanced head-and-neck cancer. (Q43890042)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11849800%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

title

ARCON: experience in 215 patients with advanced head-and-neck cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11849800%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11849800%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Johannes H.A.M. Kaanders

1

object named as

Johannes H A M Kaanders

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11849800%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

author name string

Lucas A M Pop

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11849800%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Henri A M Marres

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11849800%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Ingolv Bruaset

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11849800%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Franciscus J A van den Hoogen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11849800%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Albert J van der Kogel

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11849800%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

language of work or name

English

0 references

publication date

1 March 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11849800%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Radiation Oncology Biology Physics

7 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11849800%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11849800%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11849800%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

769-778

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11849800%20AND%20SRC:MED&resulttype=core&format=json

A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer

7 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902678-5

7 January 2021

Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902678-5

7 January 2021

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902678-5

7 January 2021

Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer - report on 3-year tumour control and normal tissue toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902678-5

7 January 2021

Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902678-5

7 January 2021

A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902678-5

7 January 2021

Radiotherapy and hyperbaric oxygen in head and neck cancer. Final report of first controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902678-5

7 January 2021

Late results of a trial of hyperbaric oxygen and radiotherapy in head and neck cancer: a rationale for hypoxic cell sensitizers?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902678-5

7 January 2021

A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902678-5

7 January 2021

Results of a European randomized trial of Etanidazole combined with radiotherapy in head and neck carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902678-5

7 January 2021

Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902678-5

7 January 2021

The histological structure of some human lung cancers and the possible implications for radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902678-5

7 January 2021

Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902678-5

7 January 2021

Effect of nicotinamide on the microregional heterogeneity of oxygen delivery within a murine tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902678-5

7 January 2021

Changes in the oxygenation of head and neck tumors during carbogen breathing

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902678-5

7 January 2021

Vascular architecture and microenvironmental parameters in human squamous cell carcinoma xenografts: effects of carbogen and nicotinamide

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902678-5

7 January 2021

Radiosensitization with normobaric oxygen and carbogen

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902678-5

7 January 2021

Carbogen and nicotinamide as radiosensitizers in a murine mammary carcinoma using conventional and accelerated radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902678-5

7 January 2021

Influence of combined use of nicotinamide and carbogen on rat spinal cord radiation tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902678-5

7 January 2021

A convenient and reliable method for carbogen breathing in man

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902678-5

7 January 2021

Improvement in human tumour oxygenation with carbogen of varying carbon dioxide concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902678-5

7 January 2021

Radiotherapy with carbogen breathing and nicotinamide in head and neck cancer: feasibility and toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902678-5

7 January 2021

Administration of nicotinamide during a five- to seven-week course of radiotherapy: pharmacokinetics, tolerance, and compliance

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902678-5

7 January 2021

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902678-5

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902678-5

7 January 2021

Effect of carbogen breathing on the physiological profile of human glioma xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902678-5

7 January 2021

Tumour radiosensitization by high-oxygen-content gases: influence of the carbon dioxide content of the inspired gas on PO2, microcirculatory function and radiosensitivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902678-5

7 January 2021

The effect of nicotinamide on spontaneous and induced activity in smooth and skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902678-5

7 January 2021

Accelerated radiotherapy, carbogen and nicotinamide (ARCON) in locally advanced head and neck cancer: a feasibility study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902678-5

7 January 2021

Accelerated fractionation radiotherapy for laryngeal cancer, acute, and late toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902678-5

7 January 2021

Altered fractionation: limited by mucosal reactions?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902678-5

7 January 2021

A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fractionated X-ray treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902678-5

7 January 2021

Relative clinical influence of tumor dose versus dose per fraction on the local control and late normal-tissue morbidity after larynx radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902678-5

7 January 2021

Hyperfractionated radiation in the treatment of squamous cell carcinomas of the head and neck: a comparison of two fractionation schedules

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902678-5

7 January 2021

Radiotherapy for squamous cell carcinoma of the supraglottic larynx: an alternative to surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902678-5

7 January 2021

Results of accelerated radiotherapy for supraglottic carcinoma: a Massachusetts General Hospital and Massachusetts Eye and Ear Infirmary experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902678-5

7 January 2021

ARCON: accelerated radiotherapy with carbogen and nicotinamide in head and neck squamous cell carcinomas. The experience of the Co-operative group of radiotherapy of the european organization for research and treatment of cancer (EORTC).

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902678-5

7 January 2021

The importance of the pre-irradiation breathing times of oxygen and carbogen (5% CO2: 95% O2) on the in vivo radiation response of a murine sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902678-5

7 January 2021

10.1016/S0360-3016(01)02678-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11849800%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference